Douglas, Michael P.
Lin, Grace A.
Trosman, Julia R.
Phillips, Kathryn A.
Funding for this research was provided by:
California Initiative to Advance Precision Medicine
National Cancer Institute (R01 CA221870)
National Human Genome Research Institute (U01 HG009599)
Article History
Received: 11 May 2021
Accepted: 28 October 2021
First Online: 6 November 2021
Declarations
:
: All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The University of California San Francisco Institutional Review Board approved an exemption for interviews conducted.
: The exemption included the ability to verbally consent participants. Written consent was not required. Verbal informed consent was obtained prior to the interview.
: No patients participated in this study. Participants verbally consented to participate with the knowledge their answers would be published without attribution to the individual.
: Kathryn Phillips and Michael Douglas receive consulting income from Illumina, Inc. unrelated to this study. Grace Lin and Julia Trosman declare that they have no conflicts of interest.
: The California Initiative to Advance Precision Medicine, the National Human Genome Research Institute, and the National Cancer Institute had no role in the preparation, review, or approval of the manuscript or decision to submit the manuscript for publication.